Reply to: "Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient"

J Hum Genet. 2020 Jun;65(6):513-514. doi: 10.1038/s10038-019-0701-6. Epub 2019 Dec 11.

Pilar Mur^{1

2

3}, Claire Palles⁴, Ian Tomlinson⁵, Laura Valle^{6

7

8}

¹ Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
² Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
³ Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
⁴ Gastrointestinal Cancer Genetics Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
⁵ Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK.
⁶ Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. lvalle@idibell.cat.
⁷ Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. lvalle@idibell.cat.
⁸ Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. lvalle@idibell.cat.

No abstract available

Publication types